Literature DB >> 1360525

Feverfew extracts and parthenolide irreversibly inhibit vascular responses of the rabbit aorta.

R W Barsby1, U Salan, D W Knight, J R Hoult.   

Abstract

Samples prepared from chloroform extracts of fresh leaves of feverfew (Tanacetum parthenium) strongly inhibited responses of rabbit aortic rings to phenylephrine, 5-hydroxytryptamine, thromboxane mimetic U46619 (9,11-dideoxy-11 alpha,9 alpha-epoxy-methano-PGF2 alpha), and angiotensin II, but the inhibition to contractions induced by potassium depolarization was much less. The inhibition was concentration- and time-dependent, non-competitive, and irreversible, and also occurred in endothelium-denuded preparations. The feverfew extracts also caused a progressive loss of tone of pre-contracted aortic rings and appeared to impair the ability of acetylcholine to induce endothelium-dependent relaxations of the tissue. These effects were mimicked by a purified preparation of an alpha-methylenebutyrolactone, parthenolide, obtained from the extract. Our results demonstrate a nonspecific and potentially toxic response to feverfew on the vasculature.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1360525     DOI: 10.1111/j.2042-7158.1992.tb05510.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  3 in total

1.  In vitro effects of essential oils of Tanacetum balsamita and carvone on the contractility of bovine ileum smooth muscles.

Authors:  Masoud Ahmadnejad-Asl-Gavgani; Masoud Maham; Bahram Dalair-Naghadeh
Journal:  Vet Res Forum       Date:  2022-03-15       Impact factor: 0.950

2.  Toxic inhibition of smooth muscle contractility by plant-derived sesquiterpenes caused by their chemically reactive alpha-methylenebutyrolactone functions.

Authors:  A J Hay; M Hamburger; K Hostettmann; J R Hoult
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

3.  Feverfew (Tanacetum parthenium L.): A systematic review.

Authors:  Anil Pareek; Manish Suthar; Garvendra S Rathore; Vijay Bansal
Journal:  Pharmacogn Rev       Date:  2011-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.